List Of Common Controlled Medications
Schedule 2 (II) Drugs The drug has a high potential for abuse. The drug has a currently accepted medical use in treatment in the United States or a currently accepted medical use with severe restrictions. Abuse of the drug may lead to severe psychological or physical dependence. The following drugs are listed as Schedule 2 (II) Drugs. by the Controlled Substances Act (CSA): The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
© Crown copyright 2017 This publication is licensed under the terms of the Open Government Licence v3.0 except where otherwise stated. To view this licence, visit or write to the Information Policy Team, The National Archives, Kew, London TW9 4DU, or email:. Where we have identified any third party copyright information you will need to obtain permission from the copyright holders concerned. This publication is available at https://www.gov.uk/government/publications/controlled-drugs-list-2/list-of-most-commonly-encountered-drugs-currently-controlled-under-the-misuse-of-drugs-legislation. Falls within paragraph 6 of Part I of Schedule 2 of the MDA 1971 (ie Class A) if in a preparation designed for administration by injection.
Falls within Schedule 5 if any preparation of one or more of the substances to which this note applies, not being a preparation designed for administration by injection, when compounded with one or more other active or inert ingredients and containing a total of not more than 100 milligrams of the substance or substances (calculated as base) per dosage unit or with a total concentration of not more than 2.5 percent (calculated as base) in undivided preparations. “Sativex” is the first cannabis-based medicine (oral spray) recognised in the UK to have medicinal properties. Following marketing authorisation, the ACMD recommended that “Sativex” should be placed in Part I of Schedule 4 to the 2001 Regulations. Falls within Schedule 5 if in a preparation designed for oral administration, containing not more than 135 mg of dextropropoxyphene (calculated as base) per dosage unit or with a concentration of not more than 2.5 percent (calculated as base) in undivided preparations.
Falls within Schedule 5 if in any preparation of difenoxin containing, per dosage unit, not more than 0.5 mg of difenoxin and a quantity of atropine sulphate equivalent to at least 5 percent of the dose of difenoxin. Falls within Schedule 5 if in any preparation of diphenoxylate containing, per dosage unit, not more than 2.5 mg of diphenoxylate calculated as base, and a quantity of atropine sulphate equivalent to at least 1 percent of the dose of diphenoxylate. GBL and 1,4-BD are not inserted into any Schedule to the 2001 Regulations.
50 Most Common Medications
Instead, because of their legitimate industrial uses, regulation 4B of the 2001 Regulations makes it lawful to import, export, produce, supply, offer to supply or possess these substances except where a person does so knowing or believing that they will be used for the purpose of human ingestion. Falls within Schedule 5 if in a preparation of medicinal opium or morphine containing (in either case) not more than 0.2 percent of morphine calculated as anhydrous morphine base, being a preparation compounded with one or more other active or inert ingredients in such a way that the opium or, as the case may be, the morphine, cannot be recovered by readily applicable means or in a yield which would constitute a risk to health.
Falls within Schedule 5 if in any powder of ipecacuanha and opium comprising: 10 percent opium, in powder, 10 percent ipecacuanha root, in powder, well mixed with 80 percent of any other powdered ingredient containing no controlled drug. Falls within Schedule 5 if in a preparation containing, per dosage unit, not more than 100 mg of propiram calculated as base and compounded with at least the same amount (by weight) of methylcellulose.